Drug-Induced Bullous Sweet Syndrome with Multiple Autoimmune Features | Zendy

Jared J. Lund | Zendy; Erik J. Stratman | Zendy; Deepa Jose | Zendy; Ling Xia | Zendy; Donald A. Wilson | Zendy; Mohammed Moizuddin | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Drug-Induced Bullous Sweet Syndrome with Multiple Autoimmune Features

Author(s) -

Jared J. Lund,

Erik J. Stratman,

Deepa Jose,

Ling Xia,

Donald A. Wilson,

Mohammed Moizuddin

Publication year - 2010

Publication title -

autoimmune diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.681

H-Index - 32

eISSN - 2090-0422

pISSN - 2090-0430

DOI - 10.4061/2010/176749

Subject(s) - medicine , relapsing polychondritis , anti nuclear antibody , vasculitis , carbamazepine , antibody , immunology , anti neutrophil cytoplasmic antibody , glomerulonephritis , autoantibody , drug , sweet syndrome , dermatology , pathology , disease , pharmacology , epilepsy , kidney , psychiatry

Sweet syndrome (SS) (Acute Febrile Neutrophilic Dermatosis) has been reported in association with autoimmune phenomena including relapsing polychondritis, drug-induced lupus, and the development of antineutrophil cytoplasmic antibodies (ANCAs). However, a combination of these autoimmune features has not been reported. Herein, we report a case of drug-induced bullous SS with ocular and mucosal involvement, glomerulonephritis, and multiple autoimmune features including clinical polychondritis with antitype II collagen antibodies, ANCAs, antinuclear (HEp-2), and antihistone antibodies in a patient on hydralazine and carbamazepine.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research